Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-20

FDA Approved: DEFERASIROX — Original Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved Sun Pharmaceutical's generic deferasirox tablet under an original ANDA for the treatment of chronic iron overload due to blood transfusions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Deferasirox (Deferasirox)

Snippet

ORIG AP for DEFERASIROX (DEFERASIROX)